China Health Industries Holdings, Inc. reported unaudited consolidated financial results For the third quarter and first nine months ended March 31, 2015. For the third fiscal quarter of 2015 ended March 31, 2015, the company reported revenue of $1,933,377, a 24% decrease on revenue of $2,555,394 for the third fiscal quarter of 2014. This decline was mainly the result of a significant reduction in sales volume of the company's two leading products, Waterlilies Soft Capsule and Propolis and Black Ant Capsule. In the third fiscal quarter of 2015, the company had a net loss of $180,800, or $0.003 per diluted share, versus net income of $135,448, or $0.002 per diluted share, for the same period a year ago. This diminished bottom line performance was primarily attributable to the aforementioned drop in quarterly revenue, and to a lesser extent an increase in operating expense of $105,245 resulting from an increase in depreciation and amortization caused by increased capital expenditure. Loss from operations was $157,872,000 against income of $190,891,000 for the same period of last year. Loss before income taxes was $155,046,000 against income of $135,448,000 for the same period of last year.

For the first nine months of fiscal 2015, the company reported revenues of $8,211,156, a 26% gain on revenues of $6,501,198 in the first nine months of fiscal 2014. This improvement was the result of significant increases in both sales price and sales volume of the Waterlilies Soft Capsule and Propolis and Black Ant Capsule products. Net income for the first nine months of fiscal 2015 was $149,455, or $0.002 per diluted share, versus a net loss of $870,555, or $0.014 per diluted share, for the same period a year earlier. This improvement was primarily attributable to the abovementioned increase in nine-month revenue, and to a lesser extent a decrease in operating expense of $252,200. Income from operations was $327,177,000 against loss of $869,339,000 for the same period of last year. Income before income taxes was $335,747,000 against loss of $870,555,000 for the same period of last year.